| Request a Trial to NEW EDGAR Online Pro Form 10-Q for AVALON PHARMACEUTICALS INC Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations The following discussion and analysis of our results of operations, financial condition and liquidity and capital resources should be read in conjunction with our unaudited consolidated financial statements and related notes contained in this Quarterly Report on Form 10-Q , as well as the audited financial statements and related notes for the fiscal year ended December 31, 2007 and "Management's Discussion and Analysis of Financial Condition and Results of Operations," contained in our Annual Report on Form 10-K , for the fiscal year ended December 31, 2007. Overview We are a biopharmaceutical company focused on the discovery, development and...
[read full story]